Press releases

The mortality reduction trend was also observed in high-risk patients with severely reduced heart function

Results of landmark heart failure trial published by New England Journal of Medicine and presented at ESC

Dr. Ken Stein to join CRM group

Boston Scientific Corporation (NYSE: BSX) today announced the schedule of the Company's major events and news announcements for the European...

Statement from Pete Nicholas, Chairman of the Board, pays tribute to Sen. Kennedy's dedication to providing access to quality health care